Correlation Between SynCore Biotechnology and Avalue Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Avalue Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Avalue Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Avalue Technology, you can compare the effects of market volatilities on SynCore Biotechnology and Avalue Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Avalue Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Avalue Technology.

Diversification Opportunities for SynCore Biotechnology and Avalue Technology

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between SynCore and Avalue is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Avalue Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalue Technology and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Avalue Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalue Technology has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Avalue Technology go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Avalue Technology

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the Avalue Technology. In addition to that, SynCore Biotechnology is 1.05 times more volatile than Avalue Technology. It trades about -0.07 of its total potential returns per unit of risk. Avalue Technology is currently generating about -0.07 per unit of volatility. If you would invest  10,200  in Avalue Technology on August 30, 2024 and sell it today you would lose (260.00) from holding Avalue Technology or give up 2.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Avalue Technology

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Avalue Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avalue Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Avalue Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

SynCore Biotechnology and Avalue Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Avalue Technology

The main advantage of trading using opposite SynCore Biotechnology and Avalue Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Avalue Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalue Technology will offset losses from the drop in Avalue Technology's long position.
The idea behind SynCore Biotechnology Co and Avalue Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.